Table 1.
Demographics and baseline clinical characteristics
| Demographics | |
| Sex (male, %) | 70% |
| Age (median, IQR) | 49.5 (42.8, 59) |
| Disease duration (median, IQR) | 14 (5, 20) |
| Clinical characteristics | |
| PASI (median, IQR) | 6.8 (3.5, 18.6) |
| BSA% (median, IQR) | 10.9 (3.6, 20.3) |
| Arthralgia (%) | 85% |
| VAS_pain (median, IQR) | 18.5 (11.75, 49.5) |
| VAS_patient global disease activity (median, IQR) | 68 (45, 74) |
| VAS_physician (median, IQR) | 35.5 (8.75, 62.75) |
| Tender joints (%) | 40% |
| TJC78 (median, IQR; mean ± SD) | 0 (0, 3.75); 2.65 ± 5.11 |
| Nail involvement (%) | 55% |
| Scalp involvement (%) | 75% |
Data are based on all 20 psoriasis patients
IQR interquartile range, SD standard deviation, PASI psoriasis area severity index, BSA body surface area, VAS visual analogue scale, TJC tender joint count